{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:09Z","timestamp":1787020869463,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jiangsu Province Postdoctoral Fund","award":["2021K444C"],"award-info":[{"award-number":["2021K444C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amphiregulin (AREG) is a ligand of epidermal growth factor receptor and participates in the fibrosis of multiple organs. However, whether AREG can regulate hypertrophic cardiomyopathy is not well known. This research aims to explore the effect of AREG on cardiac hypertrophy, and whether the oxidative stress and apoptosis was involved in the influence of AREG on cardiac hypertrophy. Angiotensin (Ang) II induced cardiac hypertrophy in mice and neonatal rat cardiomyocytes (NRCMs) or HL-1 cells in vitro. AREG expressions raised in the heart of mice. After AREG downregulation, the increases of Ang II induced cardiac weight and cardiomyocytes area were inhibited. Down-regulation of AREG could inhibit Ang II induced the increases of atrial natriuretic peptide, brain natriuretic peptide, beta-myosin heavy chain in the heart of mice, and NRCMs and HL-1 cells. The enhancement of oxidative stress in mice heart with Ang II treatment was alleviated by AREG knockdown. The raises of Ang II induced Bax and cleaved caspase3 in mice heart were inhibited by AREG downregulation. AREG downregulation reduced myocardial hypertrophy via inhibition of oxidative and apoptosis. AREG may be a target for future cardiac hypertrophy treatment.<\/jats:p>","DOI":"10.1186\/s13062-022-00334-w","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:02:52Z","timestamp":1661126572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Mingyue","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"334_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10741-021-10171-0","volume":"27","author":"Z Hajializadeh","year":"2022","unstructured":"Hajializadeh Z, Khaksari M. The protective effects of 17-beta estradiol and SIRT1 against cardiac hypertrophy: a review. Heart Fail Rev. 2022;27:725\u201338.","journal-title":"Heart Fail Rev"},{"key":"334_CR2","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s10741-020-09959-3","volume":"26","author":"H Lei","year":"2021","unstructured":"Lei H, Hu J, Sun K, Xu D. The role and molecular mechanism of epigenetics in cardiac hypertrophy. Heart Fail Rev. 2021;26:1505\u201314.","journal-title":"Heart Fail Rev"},{"key":"334_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.omtn.2021.06.006","volume":"25","author":"LHH Aung","year":"2021","unstructured":"Aung LHH, Jumbo JCC, Wang Y, Li P. Therapeutic potential and recent advances on targeting mitochondrial dynamics in cardiac hypertrophy: a concise review. Mol Ther Nucl Acids. 2021;25:416\u201343.","journal-title":"Mol Ther Nucl Acids"},{"key":"334_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00726-018-2583-x","volume":"50","author":"C Liu","year":"2018","unstructured":"Liu C, Yang CX, Chen XR, et al. Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats. Amino Acids. 2018;50:1071\u201381.","journal-title":"Amino Acids"},{"key":"334_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2021.170669","volume":"146","author":"T Shen","year":"2021","unstructured":"Shen T, Liu Y, Dong S, et al. Alarin moderated myocardial hypertrophy via inhibiting cyclic adenosine monophosphate\/protein kinase a signaling pathway to attenuate autophagy. Peptides. 2021;146: 170669.","journal-title":"Peptides"},{"key":"334_CR6","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1038\/s41467-021-24215-4","volume":"12","author":"D Vanhoutte","year":"2021","unstructured":"Vanhoutte D, Schips TG, Vo A, et al. Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy. Nat Commun. 2021;12:3928.","journal-title":"Nat Commun"},{"key":"334_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174277","volume":"907","author":"R Li","year":"2021","unstructured":"Li R, Qi Y, Yuan Q, et al. Protective effects of dioscin against isoproterenol-induced cardiac hypertrophy via adjusting PKCepsilon\/ERK-mediated oxidative stress. Eur J Pharmacol. 2021;907: 174277.","journal-title":"Eur J Pharmacol"},{"key":"334_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.732952","volume":"9","author":"J Adu-Amankwaah","year":"2021","unstructured":"Adu-Amankwaah J, Adzika GK, Adekunle AO, et al. ADAM17, a key player of cardiac inflammation and fibrosis in heart failure development during chronic catecholamine stress. Front Cell Dev Biol. 2021;9: 732952.","journal-title":"Front Cell Dev Biol"},{"key":"334_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00395-018-0669-y","volume":"113","author":"L Liu","year":"2018","unstructured":"Liu L, Jin X, Hu CF, et al. Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway. Basic Res Cardiol. 2018;113:12.","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"334_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/biomedicines10020393","volume":"10","author":"NS Dhalla","year":"2022","unstructured":"Dhalla NS, Elimban V, Bartekova M, Adameova A. Involvement of oxidative stress in the development of subcellular defects and heart disease. Biomedicines. 2022;10(2):393.","journal-title":"Biomedicines"},{"key":"334_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2022.170773","volume":"152","author":"M Ji","year":"2022","unstructured":"Ji M, Zuo Z, Zhang M, Xu Z, Hu G. Osteocrin alleviates cardiac hypertrophy via attenuating oxidative stress. Peptides. 2022;152: 170773.","journal-title":"Peptides"},{"key":"334_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1440-1681.2007.04585.x","volume":"34","author":"JR McMullen","year":"2007","unstructured":"McMullen JR, Jennings GL. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol. 2007;34:255\u201362.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"334_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11239-019-02026-1","volume":"49","author":"RC Becker","year":"2020","unstructured":"Becker RC, Owens AP 3rd, Sadayappan S. Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy. J Thromb Thrombolysis. 2020;49:177\u201383.","journal-title":"J Thromb Thrombolysis"},{"key":"334_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174858","volume":"920","author":"YK Cui","year":"2022","unstructured":"Cui YK, Hong YX, Wu WY, et al. Acacetin ameliorates cardiac hypertrophy by activating Sirt1\/AMPK\/PGC-1alpha pathway. Eur J Pharmacol. 2022;920: 174858.","journal-title":"Eur J Pharmacol"},{"key":"334_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41420-022-00895-9","volume":"8","author":"X Du","year":"2022","unstructured":"Du X, Liu T, Shen C, et al. Anti-fibrotic mechanism of SPP1 knockdown in atrial fibrosis associates with inhibited mitochondrial DNA damage and TGF-beta\/SREBP2\/PCSK9 signaling. Cell Death Discov. 2022;8:246.","journal-title":"Cell Death Discov"},{"key":"334_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-021-00434-y","volume":"7","author":"R Yue","year":"2021","unstructured":"Yue R, Zheng Z, Luo Y, et al. NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin. Cell Death Discov. 2021;7:50.","journal-title":"Cell Death Discov"},{"key":"334_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174932","volume":"923","author":"K Zhao","year":"2022","unstructured":"Zhao K, Li Y, Zhou Z, et al. Ginkgolide A alleviates cardiac remodeling in mice with myocardial infarction via binding to matrix metalloproteinase-9 to attenuate inflammation. Eur J Pharmacol. 2022;923: 174932.","journal-title":"Eur J Pharmacol"},{"key":"334_CR18","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41467-021-22178-0","volume":"12","author":"J Sugita","year":"2021","unstructured":"Sugita J, Fujiu K, Nakayama Y, et al. Cardiac macrophages prevent sudden death during heart stress. Nat Commun. 2021;12:1910.","journal-title":"Nat Commun"},{"key":"334_CR19","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/ALN.0000000000001026","volume":"124","author":"Y Xu","year":"2016","unstructured":"Xu Y, Meng C, Liu G, et al. Classically activated macrophages protect against lipopolysaccharide-induced acute lung injury by expressing amphiregulin in mice. Anesthesiology. 2016;124:1086\u201399.","journal-title":"Anesthesiology"},{"key":"334_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4049\/jimmunol.1502479","volume":"197","author":"L Ding","year":"2016","unstructured":"Ding L, Liu T, Wu Z, et al. Bone marrow CD11c+ cell-derived amphiregulin promotes pulmonary fibrosis. J Immunol. 2016;197:303\u201312.","journal-title":"J Immunol"},{"key":"334_CR21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1165\/ajrcmb.11.5.7524566","volume":"11","author":"DK Madtes","year":"1994","unstructured":"Madtes DK, Busby HK, Strandjord TP, Clark JG. Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am J Respir Cell Mol Biol. 1994;11:540\u201351.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"334_CR22","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/hep.22437","volume":"48","author":"MJ Perugorria","year":"2008","unstructured":"Perugorria MJ, Latasa MU, Nicou A, et al. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology. 2008;48:1251\u201361.","journal-title":"Hepatology"},{"key":"334_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111950","volume":"390","author":"L Liu","year":"2020","unstructured":"Liu L, Song S, Zhang YP, et al. Amphiregulin promotes cardiac fibrosis post myocardial infarction by inducing the endothelial-mesenchymal transition via the EGFR pathway in endothelial cells. Exp Cell Res. 2020;390: 111950.","journal-title":"Exp Cell Res"},{"issue":"2","key":"334_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/antiox11020336","volume":"11","author":"LU Pagan","year":"2022","unstructured":"Pagan LU, Gomes MJ, Gatto M, Mota GAF, Okoshi K, Okoshi MP. The role of oxidative stress in the aging heart. Antioxidants (Basel). 2022;11(2):336.","journal-title":"Antioxidants (Basel)"},{"key":"334_CR25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12265-010-9184-8","volume":"3","author":"J Kuroda","year":"2010","unstructured":"Kuroda J, Sadoshima J. NADPH oxidase and cardiac failure. J Cardiovasc Transl Res. 2010;3:314\u201320.","journal-title":"J Cardiovasc Transl Res"},{"key":"334_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173389","volume":"883","author":"N Rani","year":"2020","unstructured":"Rani N, Arya DS. Chrysin rescues rat myocardium from ischemia-reperfusion injury via PPAR-gamma\/Nrf2 activation. Eur J Pharmacol. 2020;883: 173389.","journal-title":"Eur J Pharmacol"},{"key":"334_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173821","volume":"893","author":"MA Sheikholeslami","year":"2021","unstructured":"Sheikholeslami MA, Ghafghazi S, Pouriran R, Mortazavi SE, Parvardeh S. Attenuating effect of paroxetine on memory impairment following cerebral ischemia-reperfusion injury in rat: the involvement of BDNF and antioxidant capacity. Eur J Pharmacol. 2021;893: 173821.","journal-title":"Eur J Pharmacol"},{"key":"334_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174917","volume":"922","author":"H Yang","year":"2022","unstructured":"Yang H, Bai J, Zhan C, et al. Hydrogen attenuates thyroid hormone-induced cardiac hypertrophy in rats by regulating angiotensin II type 1 receptor and NADPH oxidase 2 mediated oxidative stress. Eur J Pharmacol. 2022;922: 174917.","journal-title":"Eur J Pharmacol"},{"key":"334_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10200-y","author":"FR Prandi","year":"2022","unstructured":"Prandi FR, Evangelista I, Sergi D, Palazzuoli A, Romeo F. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants. Heart Fail Rev. 2022. https:\/\/doi.org\/10.1007\/s10741-021-10200-y.","journal-title":"Heart Fail Rev"},{"key":"334_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.110.943431","volume":"122","author":"K Toischer","year":"2010","unstructured":"Toischer K, Rokita AG, Unsold B, et al. Differential cardiac remodeling in preload versus afterload. Circulation. 2010;122:993\u20131003.","journal-title":"Circulation"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-022-00334-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-022-00334-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-022-00334-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:03:59Z","timestamp":1661126639000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-022-00334-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["334"],"URL":"https:\/\/doi.org\/10.1186\/s13062-022-00334-w","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"22 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal procedures were approved by the Experimental Animal Care and Use Committee of Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}